SARS-CoV-2 Neutralizing Antibody Rapid Test

Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

SARS-CoV-2 IgG/IgM Rapid Qualitative Test

The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.

SARS-CoV-2 Antigen Rapid Qualitative Test

The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

CMV IgG/IgM Rapid Test (Fluorescence Immunoassay)

TheCMV IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toCMV in human serum. IgG results with this assay are used to indicate past or recent infection with CMV. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recent CMV infections. CMV IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Cytomegalovirus (CMV) infection -For in vitro diagnostic use only. For professional use only.

TT4 Rapid Quantitative Test

TT4 is the main product of thyroid secretion and is an essential ingredient in the integrity of the hypothalamic-pituitary gland. The TT4 measures can be used for the diagnosis of hyperthyroidism, primary and secondary, and TT4 inhibition of treatment.

NGAL Rapid Quantitative Test

NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2, sidero- calin) is a novel biomarker for diagnosing acute kidney injury (AKI). Under normal conditions NGAL levels are low in urine and plasma Still, they rise sharply from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any signiﬁcant rise in serum creatinine.

5 in 1 (cTnI/ CK-MB/ Myo/ NT-proBNP/ D-Dimer) Rapid Quantitative Test

Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain, suspected Acute Coronary Syndrome(ACS) and Heart Failure(HF), etc.

TSH Rapid Quantitative Test(Chemiluminescence Immunoassay)

TSH Rapid Quantitative Test(Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the thyroid stimulating hormone concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.

Product Name	SARS-COV-2 Neutralizing Antibody Rapid Test
Sample Type	Serum/Plasma
Loading Volume	80 uL
Reaction Time	10 min
Interpretation of Results	Negative: <1.5 IU/ml；Positive: ≥1.5 IU/ml
Shelf Life	24 months
Storage Condition	2-30℃
Unit	25 kits/box

Solutions

Covid-19 Solution

SARS-CoV-2 Neutralizing Antibody Rapid Test